Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Background: Randomized trials and observational of patients with cervical artery dissection showed no significant difference in ischemic stroke risk with anticoagulation versus antiplatelet therapy.

The leading cause of cervical cancer is infection with the Human papillomavirus (HPV). In fact, HPV is responsible for roughly 99% of all cervical cancers and is one of the most common sexually ...

Introduction: Patients with traumatic vertebral artery injuries (TVAI ... such as spinal fixation for concomitant cervical spine injuries. The dilemma between risk of perioperative bleeding and ...

What are common signs and symptoms of cervical cancer? Common symptoms of cervical cancer include: vaginal bleeding after intimacy, vaginal bleeding between periods, vaginal bleeding after ...

“However, it is a common symptom of cancer.” He said bleeding after sex or menopause is particularly worrisome. Cervical cancer is most frequently diagnosed in women between 35 and ...

If you experience vaginal bleeding or pain that could extend to your lower back, pelvis or lower abdomen during or after sex, this could be a sign of cervical cancer. However, a doctor from ...

A mum who battled cervical cancer is hopeful the disease could be eradicated ... Clare, now 38, told STV News: “I had really heavy vaginal bleeding before my diagnosis, passing clots the size of the ...

ranging from unusual bleeding to pelvic pain. Women’s health expert and founder of gynaecological health company Daye, Valentina Milanova, tells us, "The five main cervical cancer symptoms that ...

Her history is otherwise significant for hypertension, coronary artery disease ... with central obesity and a very short neck. Cervical examination revealed massive soft tissue swelling and ...

Bleeding is a symptom, and cervical cancer is most common in women aged 30 to 34. Sadly, every year around 850 women die of it, with only 51 per cent of women surviving for 10 years after diagnosis.